Abstract:Background and purpose: MORC2 (microrchidia family CW-type zinc finger 2, MORC2) is a newly identified chromatin remodeling protein that plays key roles in DNA-based biological processes including gene transcription and DNA damage repair. However, its functional role in breast cancer development and progression re-mains unknown. ALDH1A3 (aldehyde dehydrogenase 1 family member A3), a member of the aldehyde dehydrogenases (ALDH) superfamily, is a putative breast cancer stem cell marker, but its regulatory mechanism in breast cancer is poor-ly characterized. This study aimed to investigate the effects of knockdown of endogenous MORC2 on the expression levels of ALDH1A3 and the breast cancer stem-like phenotype in MCF-7 cells. Methods: Human breast cancer MCF-7 cells were infected with negative control short hairpin RNAs (shNC) and specific shRNAs targeting human MORC2 (shMORC2), followed by selection with puromycin to generate stable MORC2 gene knockdown cell lines. Western blot and real-time fluorescent quantitative polymerase chain reaction (RTFQ-PCR) were used to examine the protein and mRNA levels of ALDH1A3 in MCF-7 cells stably expressing shNC and shMORC2. Microsphere formation and fluo-rescence-activated cell sorting (FACS) assays were used to analyze the effects of knockdown of MORC2 on the breast cancer stem-like phenotype. Results: Western blot and RTFQ-PCR analyses revealed that the protein and mRNA levels of ALDH1A3 were significantly down-regulated in shMORC2 expressing cells as compared with shNC -transfected control cells. Moreover, mammosphere formation assay showed that knockdown of endogenous MORC2 in MCF-7 cells significantly reduced the ability of cells to form microspheres. Consistently, FACS assays demonstrated that shMORC2-transfected cells had a lower proportion of ALDH-positive stem cells as compared with shNC expressing cells. In contrast, knockdown of MORC2 did not significantly affect the CD44+CD24- stem cell population. Conclusion:MORC2 promotes a breast cancer stem-like phenotype through, at least in part, regulating ALDH1A3 expression.

CRB3 Downregulation Confers Breast Cancer Stem Cell Traits Through TAZ/β-catenin

Elevated CRB3 Expression Suppresses Breast Cancer Stemness by Inhibiting Β‐catenin Signalling to Restore Tamoxifen Sensitivity

CRMP4 Suppresses Cervical Cancer Cell Proliferation and EMT Through the Wnt/β-catenin Pathway

Crumbs Protein Homolog 3 (CRB3) Expression is Associated with Oestrogen and Progesterone Receptor Positivity in Breast Cancer

SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation

CRB3 Regulates Contact Inhibition by Activating the Hippo Pathway in Mammary Epithelial Cells

Rab13 sustains breast cancer stem cells by supporting tumor-stroma crosstalk

Rab13 Sustains Breast Cancer Stem Cells by Supporting Tumor-Stroma Cross-talk.

Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and AKT activation

ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3.

ZFHX3 Promotes the Proliferation and Tumor Growth of ER-Positive Breast Cancer Cells Likely by Enhancing Stem-Like Features and MYC and TBX3 Transcription

Cell Polarity Protein Crb3 Is An Independent Favorable Prognostic Factor For Clear Cell Renal Cell Carcinoma

MLL3 Suppresses Tumorigenesis Through Regulating TNS3 Enhancer Activity

Downregulation of CXCR7 Inhibits Proliferative Capacity and Stem Cell-Like Properties in Breast Cancer Stem Cells

Identification of TAZ-Dependent Breast Cancer Vulnerabilities Using a Chemical Genomics Screening Approach

Β-Catenin and NF-κB Co-Activation Triggered by TLR3 Stimulation Facilitates Stem Cell-Like Phenotypes in Breast Cancer

The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells

Mir-376C-3p Modulates the Properties of Breast Cancer Stem Cells by Targeting RAB2A.

Zinc finger and SCAN domain containing 1, ZSCAN1, is a novel stemness-related tumor suppressor and transcriptional repressor in breast cancer targeting TAZ

Notch1 Induces Epithelial-Mesenchymal Transition and the Cancer Stem Cell Phenotype in Breast Cancer Cells and STAT3 Plays a Key Role.

Chromatin remodeling protein MORC2 promotes a breast cancer stem-like phenotype by regulating ALDH1A3 expression